UQCRC2

ubiquinol-cytochrome c reductase core protein 2, the group of M16 metallopeptidases|Mitochondrial complex III: ubiquinol-cytochrome c reductase complex subunits

Basic information

Region (hg38): 16:21953288-21983660

Links

ENSG00000140740NCBI:7385OMIM:191329HGNC:12586Uniprot:P22695AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • mitochondrial complex III deficiency (Supportive), mode of inheritance: AR
  • mitochondrial complex III deficiency nuclear type 5 (Strong), mode of inheritance: AR
  • mitochondrial disease (Moderate), mode of inheritance: AR
  • mitochondrial complex III deficiency nuclear type 5 (Moderate), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Mitochondrial complex III deficiency, nuclear type 5ARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingBiochemical; Neurologic23281071; 33865955

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the UQCRC2 gene.

  • not_provided (97 variants)
  • not_specified (54 variants)
  • Mitochondrial_complex_III_deficiency_nuclear_type_5 (14 variants)
  • UQCRC2-related_disorder (7 variants)
  • Mitochondrial_disease (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the UQCRC2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000003366.4. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
24
clinvar
24
missense
2
clinvar
2
clinvar
69
clinvar
3
clinvar
2
clinvar
78
nonsense
1
clinvar
1
start loss
0
frameshift
3
clinvar
1
clinvar
4
splice donor/acceptor (+/-2bp)
3
clinvar
2
clinvar
5
Total 2 8 73 27 2

Highest pathogenic variant AF is 0.000008675445

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
UQCRC2protein_codingprotein_codingENST00000268379 1431001
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.000002860.9841257140321257460.000127
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.9512072490.8300.00001282928
Missense in Polyphen2747.1310.57287564
Synonymous0.6398188.70.9140.00000452911
Loss of Function2.191324.80.5240.00000123303

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0002060.000206
Ashkenazi Jewish0.00009930.0000992
East Asian0.0004360.000435
Finnish0.0001390.000139
European (Non-Finnish)0.00007940.0000791
Middle Eastern0.0004360.000435
South Asian0.0001310.000131
Other0.0001630.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: This is a component of the ubiquinol-cytochrome c reductase complex (complex III or cytochrome b-c1 complex), which is part of the mitochondrial respiratory chain. The core protein 2 is required for the assembly of the complex.;
Disease
DISEASE: Mitochondrial complex III deficiency, nuclear 5 (MC3DN5) [MIM:615160]: A disorder of the mitochondrial respiratory chain resulting in a highly variable phenotype depending on which tissues are affected. Clinical features include mitochondrial encephalopathy, psychomotor retardation, ataxia, severe failure to thrive, liver dysfunction, renal tubulopathy, muscle weakness and exercise intolerance. {ECO:0000269|PubMed:23281071}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Cardiac muscle contraction - Homo sapiens (human);Non-alcoholic fatty liver disease (NAFLD) - Homo sapiens (human);Alzheimer,s disease - Homo sapiens (human);Huntington,s disease - Homo sapiens (human);Thermogenesis - Homo sapiens (human);Oxidative phosphorylation - Homo sapiens (human);Parkinson,s disease - Homo sapiens (human);Electron Transport Chain;Respiratory electron transport;The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. (Consensus)

Recessive Scores

pRec
0.281

Intolerance Scores

loftool
0.681
rvis_EVS
0.22
rvis_percentile_EVS
68.27

Haploinsufficiency Scores

pHI
0.367
hipred
Y
hipred_score
0.704
ghis
0.562

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
S
essential_gene_gene_trap
E
gene_indispensability_pred
E
gene_indispensability_score
0.980

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Uqcrc2
Phenotype

Gene ontology

Biological process
oxidative phosphorylation;protein processing involved in protein targeting to mitochondrion;aerobic respiration
Cellular component
nucleoplasm;mitochondrion;mitochondrial inner membrane;mitochondrial respiratory chain complex III;mitochondrial respiratory chain complex IV;mitochondrial processing peptidase complex;myelin sheath
Molecular function
endopeptidase activity;protein binding;protein-containing complex binding;metal ion binding